Macroimmunology and immunotherapy of cancer

Immunotherapy
Duane H HamiltonPeter A Bretscher

Abstract

Cytotoxic T lymphocytes (CTLs), associated with Th1 responses, are the most important mediators of resistance against most tumors. We argue that most murine tumors grow progressively when a significant Th2 component to their immune response develops, which is associated with the downregulation of the CTL response. We outline recent evidence that strongly supports this Th2-skewing hypothesis as the prevalent mechanism of tumor escape in murine systems. We describe the conceptual grounds and evidence for the 'threshold hypothesis' that proposes how the Th1/Th2 phenotype of an immune response generated against 'nonliving' antigens is determined. We suggest that this threshold hypothesis also accurately describes how the Th1/Th2 phenotype of murine antitumor immune responses is determined, as this hypothesis can account for the critical and known features of these immune responses. The efficacy of several manipulations that prevent or arrest progressive tumor growth in murine models, through their effects on the antitumor immune response, can be understood within the context of the threshold hypothesis. Indirect evidence supports the view that similar relationships between cancers and the immune system are present in humans. We pro...Continue Reading

References

Jan 1, 1977·Advances in Cancer Research·S A Rosenberg, W D Terry
Jun 15, 1989·Cancer·M J Wizenberg
Jan 1, 1985·Advances in Cancer Research·R J North
Aug 1, 1974·Cellular Immunology·P A Bretscher
Jun 1, 1974·The Journal of Experimental Medicine·P H LagrangeT E Miller
Jan 1, 1970·Annual Review of Microbiology·K E Hellström, I Hellström
Mar 1, 1971·The Journal of Experimental Medicine·M N Pearson, S Raffel
Jul 1, 1968·Cancer·H J Norris, H B Taylor
Jan 1, 1983·Advances in Cancer Research·E Gorelik
Jan 1, 1984·Advances in Immunology·R J North
Oct 1, 1981·The Australian Journal of Experimental Biology and Medical Science·G F MitchellE Handman
Feb 1, 1995·The Journal of Experimental Medicine·C S HsiehK M Murphy
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
May 28, 1993·Science·J SalkG M Shearer
Jun 1, 1997·Methods : a Companion to Methods in Enzymology·E De PlaenT Boon
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·P A Bretscher
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·M GerloniM Zanetti
May 10, 2001·Scandinavian Journal of Infectious Diseases·P BretscherG Wei
Sep 8, 2001·Nature Immunology·M SchnareR Medzhitov
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·A CerwenkaL L Lanier
Nov 26, 2002·Immunological Reviews·Pierre Van Der BruggenThierry Boon
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.